title: Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis.
authors.forename: C S
authors.initials: CS
authors.lastname: Haworth
authors.forename: P L
authors.initials: PL
authors.lastname: Selby
authors.forename: A K
authors.initials: AK
authors.lastname: Webb
authors.forename: E B
authors.initials: EB
authors.lastname: Mawer
authors.forename: J E
authors.initials: JE
authors.lastname: Adams
authors.forename: T J
authors.initials: TJ
authors.lastname: Freemont
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects; D001847:Bone Diseases / Q000139:chemically induced*; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced*; D000077268:Pamidronate
chemical_list: D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate